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Context: The liver is crucial to maintain energy homeostasis during exercise. Skeletal muscle-
derived metabolites can contribute to the regulation of hepatic metabolism.
Objective: We aim to elucidate which metabolites are released from the working muscles and 
taken up by the liver in exercising humans and their potential influence on hepatic function.
Methods: In two separate studies, young healthy men fasted overnight and then performed an 
acute bout of exercise. Arterial-to-venous differences of metabolites over the hepato-splanchnic 
bed and over the exercising and resting leg were investigated by capillary electrophoresis- and 
liquid chromatography-mass spectrometry metabolomics platforms. Liver transcriptome data of 
exercising mice were analyzed by pathway analysis to find a potential overlap between exercise-
regulated metabolites and activators of hepatic transcription.
Results: During exercise, hepatic O2 uptake and CO2 delivery were increased two-fold. In 
contrast to all other free fatty acids (FFA), those FFA with 18 or more carbon atoms and a high 
degree of saturation showed a constant release in the liver vein and only minor changes by 
exercise. FFA 6:0 and 8:0 were released from the working leg and taken up by the hepato-
splanchnic bed. Succinate and malate showed a pronounced hepatic uptake during exercise and 
were also released from the exercising leg. The transcriptional response in the liver of exercising 
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mice indicates the activation of HIF-, NRF2-, and cAMP-dependent gene transcription. These 
pathways can also be activated by succinate.
Conclusion: Metabolites circulate between working muscles and the liver and may support the 
metabolic adaption to exercise by acting both as substrates and as signaling molecules. (J Clin 
Endocrinol Metab 105: 1196–1209, 2020)
Key Words:  Capillary electrophoresis, metabolomics, succinate, exercise, liver, cAMP
For several decades, research has focused on the working skeletal muscle to understand how the 
muscle can achieve the pronounced increase in sub-
strate oxidation that is necessary to provide adenosine 
triphosphate (ATP) for muscle contraction and move-
ment. However, physical exercise is not possible without 
orchestrated cooperation of several tissues to support 
muscular work and to maintain metabolic homoeostasis. 
The central organ in this energy-demanding condition is 
the liver. Hepatic metabolism is crucial for glucose and 
lipid homoeostasis, for the recycling of metabolites and 
for the detoxifying of metabolic waste (1). Knowledge 
of the hepatic contribution to metabolism during acute 
exercise is mainly based on mouse studies and only a 
few human exercise studies (2). In humans, collection 
of blood samples from the hepatic vein and periph-
eral arteries has been employed to analyze arterial-to-
hepato-splanchnic differences of selected metabolites 
and thus assess their hepato-splanchnic fluxes during 
exercise. These studies verified the exercise-induced in-
crease in hepatic glucose output, the increased uptake 
of the gluconeogenic precursors lactate, pyruvate, and 
glycerol, of some amino acids, and of palmitate and 
oleate (3–5). The change in the hepato-splanchnic sub-
strate fluxes is dependent on the duration and intensity 
of the exercise bout (6). In a recent study, we expanded 
the knowledge base on exercise-regulated metabolite 
fluxes over the hepato-splanchnic bed by performing 
targeted liquid chromatography-mass spectrometry 
(LC-MS) analysis of acylcarnitines in the hepatic vein, 
the femoral vein of the exercising and the resting leg, 
and peripheral arterial samples (7). Exercise amplifies 
the release of medium-chain acylcarnitines from the 
exercising leg and the uptake in the hepato-splanchnic 
bed, reflecting the huge increase in fatty acid oxidation 
in the working muscle and the function of the liver to 
buffer excess circulating metabolites by their uptake 
and conversion. In contrast, the liver constantly releases 
C2- and C3-carnitine during exercise, indicating an ex-
cess production of acetyl-CoA and propionyl-CoA (7).
All these data suggest that exercise is an energy-
demanding metabolic challenge for the liver that goes 
along with the need for increased ATP production to 
maintain biosynthesis of substrates and recycling of 
metabolites. Consistent with this, analyses of hep-
atic tissue of mice after one acute bout of exercise re-
vealed a pronounced change in the hepatic energy state 
with a drop in ATP, a huge increase in adenosine 
monophosphate (AMP), and activation of the AMP-
activated kinase (8, 9). Transcriptome analyses in mice 
revealed that this is accompanied by profound alter-
ations in hepatic transcript levels related to adaptive 
responses in glucose and fatty acid metabolism (10). 
Notably, studies on the release of hepatokines from the 
liver during or immediately after exercise in humans 
mirror the exercise-induced increase of the respective 
transcripts in exercising mice (11).
In humans, collection of hepatic tissue biopsies 
for molecular investigations before and immediately 
after exercise is not feasible. But by applying 2 com-
plementary metabolomics analyses, capillary electro-
phoresis time-of-flight mass spectrometry (CE-TOF/
MS) and ultra-high-performance liquid chromatog-
raphy–quadruple-time-of-flight mass spectrometry 
(UHPLC-Q-TOF/MS), we can obtain a global picture 
of exercise-induced changes in the hepatic release or 
uptake of metabolites and thereby deepen our under-
standing of the hepatic contribution to exercise metab-
olism. First, we analyzed the metabolome in arterial and 
hepatic vein samples obtained at 8 time points during 
and after a 120-minute aerobic exercise trial at 60% 
VO2max to identify metabolites exhibiting exercise-
induced changes. Next, we investigated which of these 
metabolites are released or taken up by the exercising 
skeletal muscle in order to obtain information on sub-
strate fluxes between liver and muscle. When compared 
with the transcriptional response observed in livers of 
exercising mice, our data indicate that substrates de-
livered from the working muscle may not only support 
hepatic metabolism, but also contribute to the regula-
tion of signaling pathways and gene transcription in the 
liver in response to exercise.
Methods and Materials
Experimental design
This work consists of 2 separate exercise studies to 
assess metabolite fluxes over the hepato-splanchnic bed 
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and over the resting and exercising leg. The studies have 
been described in detail previously (12, 13), were exe-
cuted in accordance with the Helsinki Declaration and 
were approved by the Scientific Ethics Committee of 
the capital region of Denmark. Subjects participating in 
the 2 studies were not identical. All subjects provided 
written informed consent to participate. In both studies, 
the participants were recreationally active and asked to 
refrain from strenuous exercise 24 hours before the ex-
perimental day. Blood was collected in EDTA-containing 
tubes, placed on ice, and immediately spun. Plasma ali-
quots were stored at −80o C until analysis.
In the hepato-splanchnic exercise, 10 healthy men 
(age, 22.9  ±  0.8  years and body mass index [BMI], 
22.6 ± 0.5 kg/m2) reported to the laboratory after an 
overnight fast (12). Catheters were inserted into the bra-
chial artery of the nondominant arm and into a liver 
vein via the right femoral vein. The subjects performed a 
2-hour cycling exercise at 60% VO2max in semi-supine 
position and remained fasting throughout the whole 
experimental period. Blood samples were obtained in 
pairs at each time point. Hepatic blood flow was meas-
ured by indocyanine green clearance (12). Samples 
obtained at baseline (0), 60, 120, 150, 180, 240, 300, 
and 360 minutes were used for metabolomics analysis. 
Samples for blood gas analysis were taken every 15 min-
utes throughout exercise and every 15 or 30 minutes 
during the recovery period. The content of oxygen (O2) 
and carbon dioxide (CO2) were measured using an ABL 
(Radiometer, Copenhagen, Denmark). Whole blood 
content of CO2 was calculated as described in (14) and 
whole blood O2 content was calculated by addition of 
O2 bound to hemoglobin with O2 dissolved in plasma. 
Finally, rates of O2 uptake and CO2 release were cal-
culated by multiplying the arterial-to-venous difference 
with the hepatic blood flow.
The effect of exercise on metabolite fluxes over the 
leg was studied by analyzing plasma samples from a 
one-legged knee extensor study where the exercising 
leg was compared to the other (resting) leg (13). Briefly, 
after an overnight fast, 9 healthy young men (age, 
20.9 ± 0.5 years and BMI, 22.6 ± 0.8 kg/m2) performed 
continuous one-legged knee-extensor exercise for 2 
hours at 50% of maximum workload on a modified 
Krogh ergometer while the contralateral leg was resting. 
Catheters were inserted retrogradely into both femoral 
veins as well as into one femoral artery. The femoral 
retrograde placement avoids a contribution from the 
veins draining the lower abdominal adipose tissue (vena 
epigastrica superficialis) and leg cutaneous and subcuta-
neous tissues (vena saphena magna), which is important 
for the study of lipid metabolism (15). The participants 
were fasted until 3 hours after the exercise bout. Blood 
flow was determined for both the resting and the exer-
cising leg using ultrasound Doppler in 3 subjects and the 
mean value was used to calculate net skeletal muscle re-
lease/uptake for all subjects. Three blood samples were 
drawn simultaneously at each time point.
Chemicals and reagents
HPLC- or MS-grade solvents acetonitrile (ACN), 
methanol (MeOH), and chloroform (CHCl3) were pur-
chased from Merck (Darmstadt, Germany) or Sigma-
Aldrich (Steinheim, Germany or St. Louis, MO). MS 
grade water or ultrapure water was purchased from 
Merck (Darmstadt, Germany) or using a Milli-Q purity 
system (Millipore, Billerica, MA).
MeOH-dissolved internal standard solution (ISS-
1) containing L-methionine sulfone, D-camphor-10-
sulfonic acid sodium salt, leucine-d3, phenylalanine-d5, 
tryptophane-d5, succinic acid-13C4, and cholic acid-d4 
(all from Sigma-Aldrich, Steinheim, Germany) was 
used to normalize signal intensity of the CE-TOF/
MS data. ACN-dissolved ISS-2 consisting of N,N-
diethyl-2-phenylacetamide, trimesic acid, disodium 
3-hydroxynaphthalene-2,7-disulfonate (all from Wako, 
Japan), and 3-aminopyrrolidine dihydrochloride 
(Aldrich, St. Louis, MO) was used to adjust the migra-
tion time of the CE-TOF/MS analysis. Internal stand-
ards of free fatty acid (FFA) 16:0-d4 (Cambridge Isotope 
Laboratories, Tewksbury, MA, USA), and FFA 22:0-d4 
(ten Brink laboratories, Amsterdam, Netherlands) dis-
solved in CHCl3/MeOH (2:1, v/v) were used to nor-
malize signal intensity of the UHPLC-Q-TOF/MS-based 
FFA analysis.
Sample preparation
Metabolite extraction for CE-TOF/MS-based 
metabolomics analysis was performed as previously de-
scribed (16). Briefly, 50 µL of plasma was mixed with 
450 μL MeOH solution containing ISS-1, followed by 
the addition of 500 μL of CHCl3. Subsequently, 200 μL 
of water was added, and samples were vortexed and 
centrifuged to form a 2-phase system. 420 μL of the 
upper layer was further centrifugally-filtered through a 
5-kDa cutoff filter (HMT, Japan) for 2.5 to 3 hours at 
4°C to remove residual proteins. The filtrate was lyoph-
ilized and stored at −80°C for later analysis. Prior to 
CE-TOF/MS metabolomics analysis, dry samples were 
preconditioned in Milli-Q water containing 50 μM ISS-
2. Extraction and deproteination for UHPLC-Q-TOF/
MS analysis of FFA not covered by CE-TOF/MS was 
performed according to a previously published protocol 
(17), using 100 μL of plasma and 300 μL of ACN.
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Metabolomics analysis
Capillary electrophoresis time-of-flight mass spec-
trometry. CE-TOF/MS analysis was performed on a 
CE system (G7100A, Agilent, Santa Clara, CA)-TOF/MS 
(G6224A, Agilent) equipped with an ESI-MS sprayer kit 
(G1607A, Agilent), a 1260 ISO pump (G1310B, Agilent) 
and a minichiller (Huber, Offenburg, Germany). A fused-
silica capillary with 80 cm × 50 μm internal diameter was 
used for sample analysis. The capillary temperature was 
maintained at 20°C. The sample tray temperature was 
set at 5°C controlled by the minichiller. The CE-TOF/MS 
coupling was realized by a coaxial sheath liquid interface. 
The sheath liquid containing MeOH/water (1:1, v/v) and 
0.1 μM hexakis (2, 2-difluoroethoxy) phosphazene was 
delivered at 10 μL/min. CE-TOF/MS data acquisition of 
plasma samples was carried out in both cation and anion 
mode. The detailed parameters of these two scan modes 
were previously described (16). FFA containing fewer 
than 12 carbon atoms were analyzed by CE-TOF/MS.
Ultra-high-performance liquid chromatography–
quadruple-time-of-flight mass spectrometry. FFA 
containing 12 or more carbon atoms were analyzed using a 
Waters ACQUITY-UHPLC system (Waters Corp, Milford, 
USA) coupled to AB SCIEX Triple Q TOF 5600 plus System 
(AB SCIEX, Framingham, USA) operated in negative ion 
mode as previously described (18) with slight modifica-
tions. The separation was performed on a 2.1 × 100 mm 
ACQUITY 1.8  µm T3 column (Waters, Milford, MA, 
USA) and the mobile phase consisted of 6.5 mM ammo-
nium bicarbonate in water (A) and 6.5 mM ammonium 
bicarbonate in 95% MeOH and water (B). The gradient 
elution started at 98% eluent A and was maintained for 1 
minute, then linearly changed to 100% eluent B within 18 
minutes and maintained for 4 minutes, and finally reverted 
back to 98% B and equilibrated for 2 minutes. Flow rate 
was 0.35 mL/min, and the column temperature was kept 
at 55°C. The ion spray voltage was set to 4500 V. Interface 
heater temperature was 500°C. Curtain gas, ion source gas 
1 and ion source gas 2 were set to 35 PSI, 50 PSI and 50 
PSI, respectively. FFA concentrations are given in µmol/L, 
concentrations of metabolites analyzed by CE-TOF/MS 
are given in arbitrary units (AU)/L.
Calculation of metabolite fluxes. Hepato-splanchnic 
and leg fluxes (negative = release or positive = uptake) 
of a metabolite (a) were calculated by multiplying the 
arterial-to-venous difference by the plasma flow:
Fluxa
Å
nmol
min
ã
=
ß
[a]artery
Å
nmol
L
ã
− [a]vein
Å
nmol
L
ã™
x Plasma f low
Å
L
min
ã
Pathway analysis of liver transcriptome data 
of mice
Upstream regulator analysis using Ingenuity 
Pathway Analysis (Qiagen, Redwood City, CA) was 
performed with recently published whole genome 
array data of liver tissue of exercising male C57BL/6N 
mice (GEO database at NCBI; GSE110747) (19). 
Data of the control group of chow-fed mice were 
used for analysis. Livers were obtained immediately 
after 1 hour of treadmill running (13 m/min and 14 
uphill slope) (19). Transcripts with a limma t-test P 
value < 0.05 and median fold change > |1.5| between 
exercised mice and sedentary mice were included in 
the analysis.
Statistics
To identify metabolites with plasma concentrations 
affected by exercise on a systemic level, a one-way 
analysis of variance (ANOVA) was performed on ar-
terial samples from the liver study (with time as fixed 
and subject as random effect). A Benjamini-Hochberg 
correction was performed with a false discovery rate 
(FDR) of 1%. A heatmap from the resulting subset of 
data was generated by unsupervised hierarchical clus-
tering, using the open-source MultiExperiment Viewer 
software (20) and employing unit variance (UV)-scaled, 
mean-centered data.
Differences in metabolite flux over the hepato-
splanchnic bed were detected using one-way ANOVA 
(time as fixed and subject as random effect) followed by 
Bonferroni post hoc test. Flux data were UV-scaled for 
the heatmap since mean-centering could lead to loss of 
directional information. The subset of metabolites ex-
hibiting a significantly different hepato-splanchnic flux 
over time according to one-way ANOVA was further as-
sessed in the one-leg exercise study, employing two-way 
ANOVA (time and resting/exercising leg flux as fixed, 
subject as random effect) followed by Bonferroni post 
hoc test.
Statistical analyses were performed using JMP 13.0 
(SAS Institute Inc, Cary, NC). A P value < 0.05 was con-
sidered statistically significant. Data are presented as 
mean ± standard error (SEM).
Results
Increase in hepato-splanchnic oxygen 
consumption during exercise
O2 uptake and CO2 release over the hepato-
splanchnic bed were significantly increased immedi-
ately after the commencement of exercise and remained 
at this elevated level until the end of the exercise bout 
(Fig. 1A and 1B) with a similar hepato-splanchnic blood 
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flow before (1.81 L/min) and during exercise (1.68 L/
min). Before exercise, O2 uptake and CO2 release from 
the hepato-splanchnic bed were 3 mmol/min. The mean 
O2 uptake over the hepato-splanchnic bed during exer-
cise was 6  mmol/min, paralleled by a CO2 release of 
5 mmol/min. In comparison, O2 uptake of the exercising 
leg in the one-legged exercise study increased about 
30-fold and reached a mean of 18  mmol/min during 
exercise, paralleled by a huge increase in CO2 release 
(Fig. 1C and 1D). Only marginal changes in O2 uptake 
and CO2 release of the resting leg were observed during 
the study. Before exercise at rest, the leg had a 3-fold 
lower O2 uptake than the hepato-splanchnic bed (1 vs 
3 mmol/min).
Exercise induces pronounced changes in the 
arterial concentration of metabolites
CE-TOF/MS metabolomics analyses were performed 
in order to analyze a broad range of metabolites in the 
blood samples. Fatty acids with a chain length of more 
than 10 carbon atoms were quantified by UHPLC-Q-
TOF/MS. The arterial plasma concentration of 77 of 
the over 200 detected metabolites was significantly 
changed (one-way ANOVA with FDR  <  1%) during 
the exercise trial (Fig.  2A). Grouping of metabol-
ites by Spearman rank-order correlation resulted in 
3 main clusters (Fig.  2A). Cluster I  contains metab-
olites that were increased at the end of the exercise 
bout and remained elevated in the recovery phase, in 
particular FFA. The metabolites in cluster II are char-
acterized by an increase in the recovery phase, while 
their concentration was unchanged or even dropped 
during exercise. In this cluster, 2-(α)-hydroxybutyrate 
and 3-(β)-hydroxybutyrate continuously increased 
until the end of the recovery phase. The participants 
stayed fasted after exercise, which could explain the 
still-elevated concentration of many metabolites in the 
recovery phase. The metabolites in cluster III showed 
an early and transient increase during exercise, and/
or a decline in the recovery phase compared to pre-
exercise values. Succinate, malate, lactate, hypoxan-
thine, FFA 6:0, FFA 7:0, and FFA 8:0 were grouped 
into this cluster since they were increased during the 
exercise bout.
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Figure 1. Blood gas fluxes in the hepato-splanchnic exercise study (1A, 1B) and one-legged knee extensor study (1C, 1D). 1A: Oxygen (O2) uptake 
and 1B: Carbon dioxide (CO2) release over the hepato-splanchnic bed. 1C: O2 uptake and 1D: CO2 release over the exercising (solid line) and 
resting leg (dashed line). Data are presented as mean ± standard error (SEM). † significant effect of time, ‡ significant effect of leg*time.
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Figure 2. Effects of exercise on systemic concentrations of metabolites detected in plasma using CE-TOF/MS and UHPLC-Q-TOF/MS in the hepato-
splanchnic exercise study. 2A: Metabolites significantly affected by exercise on the arterial (systemic) level, clustered by Spearman rank-order 
correlation. Each column represents unit variance (UV)-scaled, mean-centered values from 1 individual. 2B: concentration (mean ± standard error 
[SEM]) and 2C: percentages of free fatty acids (FFA), summed up according to chain length and degree of saturation (Abbreviations: mu, mono-
unsaturated; pu, poly-unsaturated; s, saturated FFA). Only FFA with a chain length of more than 10 carbon atoms, from the UHPLC-Q-TOF/MS 
analysis, were included.
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/article-abstract/105/4/1196/5673517 by D
anish R
egions user on 16 June 2020
1202  Hu et al  Muscle-Liver Substrate Fluxes During Exercise J Clin Endocrinol Metab, April 2020, 105(4):1196–1209
Exercise increases the proportion of 
monounsaturated FFA in plasma
Exercise did not cause an equal increase in the arterial 
plasma concentration of all FFA species. Immediately at 
the end of the exercise bout, there was no observed in-
crease in saturated FFA with a chain length of 18 and 
more carbon atoms (Fig. 2B). This resulted in an increase 
in the proportion of several mono- and polyunsaturated 
FFA, which were elevated after exercise. This effect was 
particularly pronounced for the abundant monounsatu-
rated FFA species (29% ± 6% before vs 44% ± 4% after 
exercise; Fig.  2C), while the proportion of the satur-
ated FFA with 18 and more carbon atoms was reduced 
(27% ± 5% before vs 13% ± 3% after exercise).
Exercise regulates the hepato-splanchnic flux of 
metabolites
The hepato-splanchnic flux of all detected metabol-
ites was calculated as the difference between the concen-
trations of arterial and hepatic vein sample multiplied by 
hepatic blood flow. During the exercise trial, the hepato-
splanchnic flux of 21 metabolites was significantly al-
tered at one or more timepoints (one-way ANOVA with 
Bonferroni post hoc test). The flux of these metabolites 
is illustrated as a heatmap (Fig. 3A) with the red color 
indicating an uptake and the blue color indicating a re-
lease from the hepato-splanchnic bed. Exercise increased 
the uptake of the medium-chain FFA 6:0 and 8:0 and of 
the long-chain FFA 14:0, 14:1, and 16:1 at 60 and/or 
120 minutes. The alterations in the uptake followed the 
changes in the arterial concentrations of individual FFA. 
Again, saturated FFA with 18 carbon atoms and more 
differed from the other FFA species because they showed 
a constantly negative hepato-splanchnic flux, indicating 
a release from the hepato-splanchnic bed (Fig. 3B). This 
opposite regulation of long-chain and very-long-chain 
saturated FFA was also observed before exercise in the 
fasting state (Table 1).
An increased uptake during or after exercise was also 
observable for succinate, malate, lactate, and pyruvate, 
and for the amino acids arginine, glutamine, and ly-
sine (Fig. 3A). Threonate and N-acetylasparagine only 
showed an uptake after 360 minutes. Of all these me-
tabolites, only succinate and FFA 8:0 were significantly 
taken up in the fasting state (Table 2). A release from the 
hepato-splanchnic bed during and/or after exercise was 
detected for 3-(β)-hydroxybutyrate, hippurate, aspar-
tate, 3-methyl-2-oxovalerate, and N5-ethylglutamine.
Increase in substrate fluxes between skeletal 
muscle and liver during exercise
Next, we studied which of the metabolites with 
exercise-induced changes in the hepato-splanchnic flux 
showed an oppositely changed flux over the exercising 
leg compared with the resting leg in the one-legged exer-
cise study. This was, as expected, the case for lactate, 
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Figure 3. Effects of exercise on the hepato-splanchnic flux of metabolites. 3A: Metabolites exhibiting significant changes in uptake (positive 
values, red) or release (negative values, blue) from the hepato-splanchnic bed. Each column represents unit variance (UV)-scaled values of the mean 
of all participants. Metabolites were ordered according to pathway and kinetics. 3B: Hepato-splanchnic flux of free fatty acids (FFA) quantified by 
UHPLC-Q-TOF/MS, summed up according to chain length and saturation (Abbreviations: mu, mono-unsaturated; pu, poly-unsaturated; s, saturated 
FFA) presented as mean ± standard error (SEM). #: significantly different from 0 minutes.
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which was released from the exercising leg after 60 min-
utes of exercise (Fig. 4A). The exercising leg also con-
tributed to the systemic increase of malate, succinate, 
FFA 6:0 and 8:0, which may support the uptake into 
the hepato-splanchnic bed (Fig. 4B–E). Thus, these me-
tabolites may circulate from the contracting muscle to 
the liver. In particular, citric acid cycle (TCA cycle) me-
tabolites malate and succinate showed similar exercise-
regulated kinetics of their arterial concentration and 
fluxes with a pronounced hepatic uptake after 60 and 
120 minutes of exercise (Fig. 4B,C). In contrast, the liver 
released 3-(β)-hydroxybutyrate. An uptake of 3-(β)-
hydroxybutyrate by the exercising leg was observed in 
the one-legged exercise study (Fig. 4F).
Fatty acids, cyclic AMP, hypoxia-induced factor 1A, 
and nuclear factor erythroid-2-related factor 2 are 
identified as upstream regulators of the hepatic 
transcriptional response to exercise
Metabolites can be shuttled into metabolic path-
ways, but also act as signaling molecules: by binding 
to membrane or nuclear receptors and to intracellular 
proteins, or as substrate for protein modifications with 
impact on transcriptional activation and epigenetic 
regulation of gene expression (21–23). In order to in-
vestigate which of the metabolites with an increased 
hepato-splanchnic uptake during exercise are poten-
tially implicated in the regulation of hepatic transcripts, 
we analyzed the acute transcriptional response of the 
liver to exercise. Since the acute regulation of hepatic 
transcripts is hardly accessible in humans, we made 
use of data from exercising mice recently published 
by our group (19). Pathway analysis of the exercise-
regulated transcripts indicated activation of peroxisome 
proliferator-activated receptor (PPAR), glucocorticoid-
activated receptor signaling, and of interleukin 6-, p53- 
and GADD45-dependent signaling (Tables 3, 4), which 
is in accordance with previous data (10). Transcription 
data also indicated pronounced cyclic AMP (cAMP)-
dependent activation of transcription factors (CREB, 
CREM, and FOXO) and activation of the hypoxia-
induced factor (HIF)1A, as well as activation of nuclear 
factor erythroid 2-related factor 2 (NRF2)-dependent 
transcription. Fatty acids and cAMP were among the 
identified endogenous substances implicated in the tran-
scriptional activation of genes (Table 4).
Discussion
In this study we provide, for the first time to our know-
ledge, a comprehensive metabolomics analysis of 
human plasma samples collected at 8 time points from 
Table 2. Metabolites analyzed by CE-TOF/MS 
exhibiting hepato-splanchnic uptake or release in 
the basal, fasting state
Hepato-
splanchnic 
flux [AU/min]
t-test  
against 0
 Mean SEM P-value
2-(α)-Hydroxybutyrate -4.06 1.64 0.0430
2-Oxobutyrate -1.56 0.35 0.0029
3-(β)-Hydroxybutyrate -20.40 7.17 0.0249
3-Phenylpropionic acid -0.33 0.11 0.0174
Citrulline -16.41 5.08 0.0120
Glutamate -19.17 4.92 0.0045
Hippurate -2.23 0.55 0.0050
Isobutyrate -2.79 1.09 0.0373
N2-Phenylacetylglutamine -0.23 0.06 0.0082
N-Acetylalanine -0.31 0.12 0.0444
Propionate -1.34 0.41 0.0133
trans-Cinnamate -0.77 0.12 0.0004
1-Methyladenosine 0.04 0.01 0.0273
2-Hydroxy-4-methylvaleric acid 0.10 0.03 0.0116
5-Oxoproline 1.83 0.40 0.0026
Alanine 22.65 6.70 0.0096
Asparagine 3.42 1.37 0.0367
Benzoate 0.48 0.15 0.0169
Citrate 9.91 2.68 0.0077
FFA 8:0 2.10 0.43 0.0017
FFA 10:0 1.24 0.32 0.0064
Guanidoacetic acid 1.35 0.35 0.0050
Methionine 2.62 1.11 0.0456
N5-Ethylglutamine 0.45 0.19 0.0459
Succinate 0.79 0.16 0.0017
Negative values indicate a hepato-splanchnic release, positive values an 
uptake. The flux was assessed by a t-test against 0 (no uptake/release), 
a P < 0.05 was considered significant.
Table 1. FFA > 10 carbon atoms exhibiting hepato-
splanchnic uptake or release in the basal, fasting state
Hepato-splanchnic  
flux [µmol/min]
t-test  
against 0
 Mean SEM P-value
FFA 17:0 -0.19 0.08 0.0499
FFA 18:0 -15.15 4.71 0.0106
FFA 20:0 -0.23 0.09 0.0263
FFA 24:0 -0.06 0.02 0.0454
FFA 24:1 -0.03 0.01 0.0157
FFA 12:0 0.73 0.17 0.0018
FFA 14:0 2.53 0.52 0.0009
FFA 14:1 0.51 0.09 0.0003
FFA 16:1 4.41 0.99 0.0016
FFA 16:2 0.06 0.01 0.0005
FFA 17:1 0.15 0.04 0.0046
FFA 18:2 7.24 1.99 0.0055
FFA 18:3 1.26 0.22 0.0003
FFA 18:4 0.05 0.01 0.0049
FFA 22:5 0.35 0.06 0.0004
FFA 22:6 1.24 0.49 0.0315
Negative values indicate a hepato-splanchnic release, positive values an 
uptake. The flux was assessed by a t-test against 0 (no uptake/release), 
a P < 0.05 was considered significant
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Figure 4. Metabolites exhibiting a significant increased uptake into or release from the hepato-splanchnic bed were further assessed for an 
opposing flux from the exercising leg. This was the case for A: lactate, B: malate, C: succinate, D: FFA 6:0, E: FFA 8:0 and F: 3-(β)-hydroxybutyrate. 
Shown are arterial (systemic) concentrations from the hepato-splanchnic exercise study (left panel), hepato-splanchnic fluxes (middle panel) 
and fluxes over the resting and exercising leg (right panel). Data are presented as mean ± standard error (SEM). †: significant effect of time; 
‡: significant effect of leg*time; #: significantly different from 0 min; *: significantly different between exercising and resting leg according to 
Bonferroni post-hoc test. Succinate showed a significant difference between exercising and resting leg after 60 minutes of exercise, but only a 
trend towards a time effect in the two-way ANOVA (P = 0.0945).
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the artery and the hepatic vein during and after an acute 
bout of exercise. The participants performed aerobic 
endurance exercise at 60% VO2max for 120 minutes. 
At this intensity, hepatic blood flow was not reduced 
and an increase in hepatic oxygen uptake was observed. 
An approximately 2-fold increase of oxygen uptake 
has also been reported in other studies performed at a 
moderate exercise intensity, such as during exercise at 
30% VO2max for 240 minutes (3), at 55% VO2max 
for 60 minutes (24), and at 60% VO2max for 120 min-
utes (25). Even with a 50% reduction in hepatic blood 
flow during intense exercise, a slightly increased oxygen 
uptake was reported (6), which underlines the capacity 
of the hepato-splanchnic region to increase oxygen ex-
traction in order to maintain metabolic processes during 
states of blood flow redistribution towards the working 
muscle (26). Together with the increase in CO2 release, 
this is a clear indication of higher metabolic activity in 
the liver of exercising humans and underlines an in-
creased demand for ATP as reported in the liver of ex-
ercising mice (8).
An important ATP-consuming metabolic process in 
the liver during exercise is the production of glucose 
from glucogenic precursors. In the overnight fasted par-
ticipants of our study, net hepato-splanchnic glucose 
production increased from 1  mmol/min to approxi-
mately 3  mmol/min (12). Gluconeogenesis accounts 
for 20% to 25% of total glucose production when 
exercise is performed after an overnight fast at 45% or 
Table 3. Canonical pathways with enriched 
exercise-regulated transcripts in the liver of mice 
after a 1h-treadmill run
Canonical pathway P-value
PPAR Signaling 6.17E-04
IL-6 Signaling 1.55E-03
PI3K Signaling in B Lymphocytes 2.24E-03
p53 Signaling 3.89E-03
Glucocorticoid Receptor Signaling 5.25E-03
IGF-1 Signaling 5.37E-03
SPINK1 General Cancer Pathway 6.92E-03
PXR/RXR Activation 7.24E-03
GADD45 Signaling 7.24E-03
NRF2-mediated Oxidative Stress Response 7.59E-03
Thrombopoietin Signaling 9.55E-03
Ingenuity canonical pathway analysis of transcripts that were signifi-
cantly different (limma t-test P < 0.05 and median fold change > |1.5|) 
between exercised and sedentary mice immediately after a 1h treadmill 
run (GSE110747 (19), only canonical pathways with a P-value < 0.01 
are shown).
Table 4. Upstream regulators implicated in the activation of genes in the liver of mice after a 1h-treadmill run
Transcriptional regulators Endogenous substances
Name Z-score P-value Name Z-score P-value
CREB1* 4.14 1.27E-15 hydrogen peroxide 3.438 1.74E-09
RELA 3.40 6.55E-09 Ca2+ 3.098 6.10E-13
FOXO3* 3.21 5.01E-10 leukotriene D4 3.095 2.10E-12
HIF1A* 2.95 1.63E-03 cyclic AMP* 2.878 5.32E-08
FOXO1* 2.94 6.85E-10 prostaglandin E2 2.588 1.06E-12
STAT3 2.85 7.35E-11 norepinephrine 2.53 4.55E-11
TP63 2.75 1.79E-04 corticosterone 2.414 1.13E-05
NFKBIA 2.72 3.32E-08 fatty acids 2.387 5.18E-06
NFKB1 2.60 6.96E-06 histamine 2.189 1.26E-04
SMAD3 2.59 5.32E-08 nitric oxide 2.173 3.25E-10
CREM* 2.50 3.83E-10    
TP53 2.49 1.33E-06  
FOXL2 2.44 2.94E-06  
CTNNB1 2.43 2.62E-03    
MYOD1 2.37 2.88E-04    
MEF2C 2.37 2.87E-06    
NUPR1 2.33 6.17E-03    
CDKN2A 2.32 1.38E-08    
MEF2D 2.20 5.93E-05    
ELK1 2.19 1.70E-06    
EGR1 2.18 4.98E-06    
PDX1 2.17 3.94E-11    
NFYA 2.16 2.29E-05    
NRF2* 2.06 3.81E-06    
STAT6 2.00 4.19E-05    
Ingenuity upstream regulator analysis of transcripts that were significantly different (limma t-test P < 0.05 and median fold change > |1.5|) between 
exercised and sedentary mice immediately after a 1h treadmill run (GSE110747; (19)). Regulators with z-score > 2.0 (ie, predicted to be activated) 
and with a p-value of overlap <0.05 are shown (other regulator groups are not included). *Transcription regulators discussed as succinate-regulated 
factors are formatted bold.
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65% of VO2peak, conditions similar to our study (27). 
Increased hepato-splanchnic uptake of the glucogenic 
substrates lactate, pyruvate, and lipolysis-derived gly-
cerol during exercise has been reported previously (4, 
28). By our CE-TOF/MS, which also covered polar me-
tabolites, we confirmed the exercise-induced increase 
in the hepato-splanchnic uptake of lactate and pyru-
vate. The exercise-dependent regulation of glycerol 
was not detectable with our approach since the filters 
used for sample preparation contain glycerol, which 
cannot be completely washed out and cannot be dis-
tinguished from plasma glycerol. Two of the amino 
acids that exhibited an increased hepato-splanchnic 
uptake during the trial, arginine and glutamine, are 
glucogenic. Other glucogenic amino acids such as ala-
nine showed already at baseline, in the fasting state, a 
positive value for the hepato-splanchnic flux and thus 
an uptake (Table 2). The findings demonstrate that our 
approach is suitable to analyze substrate fluxes over 
the hepato-splanchnic bed.
A constant finding of our study is that the chain 
length and degree of saturation has a strong influence 
on the hepato-splanchnic exchange of FFA during exer-
cise, but also in the baseline condition after the over-
night fast. Similar data have been reported earlier, with 
high hepatic uptake rates for oleate (FFA 18:1), lino-
leate (FFA 18:2), laureate (FFA 12:0) and myristate (FFA 
14:0) during exercise (29), while stearate (FFA 18:0) 
has a negative arterial-hepatic vein difference during 
exercise (5). The broad coverage of FFA by UHPLC-
Q-TOF/MS-based metabolomics in our study makes 
a more systematic interpretation possible. In general, 
FFA with at least 18 carbon atoms and a high degree 
of saturation showed a negative hepato-splanchnic flux 
at baseline, and only a marginal increase in the arterial 
concentration after exercise. The net release of FFA 
from the hepato-splanchnic bed is presumably due to 
fatty acid delivery from intraabdominal adipose tissue 
(4), and these adipose depots contain higher propor-
tion of long-chain saturated fatty acids compared with 
subcutaneous depots (30). The increase in the systemic 
concentration is partly due to an overspill of fatty acids 
from exercise-induced lipolysis of subcutaneous adipose 
tissue, which contains higher proportions of oleate and 
linoleate compared with plasma concentrations but less 
stearate (31). Thus, the different increase in the arterial 
concentration of these fatty acids reflects the adipose 
depot-specific fatty acid composition of triglycerides. As 
a consequence, a higher proportion of unsaturated FFA 
was found in plasma after exercise compared with pre-
exercise values, which is in accordance with previous re-
ports (32). The data also indicate that the contribution 
of other nonhepatic intraabdominal tissues to the meas-
ured hepato-splanchnic fluxes must be considered.
A novel finding is the efflux of FFA 6:0 and FFA 8:0 
from the exercising muscle and their increased uptake 
into the hepato-splanchnic bed. Since the respective 
C6:0 and C8:0 acylcarnitine esters are strongly in-
creased in exercising muscle tissue (14- and 8-fold, 
respectively) (7), fatty acid chain shortening during 
β-oxidation followed by hydrolysis of acylcarnitine 
esters is a likely explanation for the increased release 
from the exercising leg. Medium-chain fatty acids are 
considered as easily accessible fuels, since they can be 
metabolized independent of proteins for binding and 
transport (33). Isolated liver perfusion studies or in-
cubation of isolated hepatocytes show an enhanced 
mitochondrial respiration, a glucose-sparing effect 
towards fatty acid oxidation and a stimulation of 
gluconeogenesis, in particular by FFA 8:0 (34, 35). An 
intriguing idea worth studying further is the potential 
relevance of muscle-derived FFA 6:0 and 8:0 for the 
adaption of hepatic metabolism to exercise.
The main rationale for employing the CE-TOF/MS ap-
proach in our study was to track the flux of a wide range 
of polar metabolites, which are not covered by common 
LC-MS–based metabolomics methods. In addition to 
the known substrate flux of lactate from the exercising 
muscle to the liver and the flux of 3-(β)-hydroxybutyrate 
from the liver to the exercising muscle, our data re-
vealed the uptake of malate and succinate into the 
hepato-splanchnic bed during exercise and their release 
from the exercising leg. There was no or only a small 
detectable uptake before exercise (Table  2) suggesting 
that the pronounced increase in arterial plasma is the 
driver of the increased uptake. Arterial concentrations 
and fluxes of malate and succinate showed similar kin-
etics during the study. Both are intermediates of the TCA 
cycle, and succinate is converted to malate via succinate 
dehydrogenase (SDH), which catalyzes the reduction to 
fumarate and fumarase, which catalyzes the hydration 
to malate. Since SDH couples the TCA cycle to the re-
spiratory chain, succinate is an electron donor and driver 
of oxidative phosphorylation, but it is also substrate for 
protein modifications and has signaling and paracrine/
endocrine effects (36). Succinate has structural similarity 
to 2-ketoglutarate and can compete for the binding to 
2-ketoglutarate-dependent dioxygenases (2-KGDD), 
causing inhibition of these enzymes (37). One prominent 
target of 2-KGDD is the transcription factor HIF, which 
was activated in the livers of exercising mice according 
to transcriptome analysis (Table  4). The inhibition of 
these enzymes by succinate causes stabilization of HIF, 
increased activation of HIF-target genes (38), and links 
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the accumulation of succinate to HIF-induced interleukin 
1beta expression (39). High fumarate concentrations 
cause S-(2-succino)-cysteine modifications of proteins, 
a process called succination (40). The succination of 
Kelch-like ECH-associated protein-1 (KEAP)1 releases 
the transcription factor NRF2 from its complex with 
KEAP1 and enables its nuclear translocation and ac-
tivation of target genes (41). The transcription factor 
NRF2 was also identified as activated in the livers of 
exercising mice (Tables  3, 4). Another mechanism for 
how elevated succinate concentrations could influence 
hepatic signaling pathways was described recently in 
mice, where the succinate-induced HIF activation leads 
to accumulation of cAMP by inhibition of its degrad-
ation (42). Notably, cAMP is a master regulator of the 
transcriptional response to exercise in the liver, which 
is responsible for the activation of the CREB1, CREM, 
and FOXO transcription factors (Table 4). Thus, accu-
mulation of succinate has been linked to the activation 
of certain transcription factors and to cAMP-dependent 
transcriptional activation, and these succinate-dependent 
pathways share a great overlap with the pathways which 
are found to be acutely activated in the liver of mice after 
exercise (43). This overlap remains speculative without 
experimental validation. Moreover, we performed this 
comparison of metabolomics with transcriptomics data 
across different species, which can be seen as another 
limitation. But human transcriptome data obtained from 
liver tissue under exercise conditions are hardly access-
ible. In conclusion, we suggest that succinate can be a 
candidate for the list of metabolic upstream regulators 
of the hepatic exercise response, such as fatty acids as 
PPAR activators and the glucagon/insulin ratio as cAMP 
inducer. Our data are a first hint that succinate accu-
mulation in hepatic tissue can support the acute tran-
scriptional response to exercise. Notably, the more than 
6-fold increase in the hepato-splanchnic uptake of suc-
cinate may cause tissue concentrations sufficient to in-
hibit 2-KGDD (44, 45).
It is intriguing to hypothesize that the working leg is a 
major source of the increased hepato-splanchnic uptake 
of the TCA metabolites, lactate, and FFA 6:0 and FFA 8:0. 
However, the metabolomics data were obtained from 2 
different exercise studies, and a direct comparison is not 
possible since the exercise modalities are different. In 
particular, the ongoing hepato-splanchnic uptake in the 
second exercise phase after the leg release peaked at 60 
minutes raises the question of other exercise-dependent 
sources of these metabolites. To the best of our know-
ledge, no human data are available to support the con-
tribution of other tissues. It can be speculated that tissues 
with increased metabolic activity during exercise, such 
as the heart, can contribute with an increased net release 
of TCA metabolites. Up to now, the release of succinate 
from the heart was mainly reported during ischemic con-
ditions (46). Another possible candidate is the adipose 
tissue, which is postulated to show increased net release 
of lactate during exercise (47).
Conclusions
The application of a global metabolomics approach 
to investigate the effect of exercise on substrate fluxes 
offers the possibility to identify metabolites exchanged 
between tissues and to elucidate group-specific differ-
ences in regulation (eg, in the hepatic uptake or sys-
temic increase of different FFA). Comparison of the 
known effects of the muscle-derived metabolites suc-
cinate and FFA 8:0 on hepatic metabolism and tran-
scriptional regulation with the exercise-dependent 
regulation of hepatic metabolic pathways reveals a 
surprising overlap. The results underline the essential 
function of the hepatic metabolism during exercise 
and support the relevance of the crosstalk of working 
muscles and the liver to exchange metabolite substrates, 
but also signaling molecules, that support and mediate 
compensatory and adaptive processes during exercise.
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